Lowering Mutant Huntingtin Levels and Toxicity: Autophagy-Endolysosome Pathways in Huntington's Disease

被引：32
作者：
Valionyte, Evelina [1 ,2 ]
Yang, Yi [1 ,2 ]
Roberts, Sheridan L. [1 ,2 ]
Kelly, Jack [1 ,2 ]
Lu, Boxun [3 ]
Luo, Shouqing [1 ,2 ]
机构：
[1] Univ Plymouth, Peninsula Sch Med, Inst Translat & Stratified Med, Res Way, Plymouth PL6 8BU, Devon, England
[2] Univ Plymouth, Peninsula Sch Dent, Inst Translat & Stratified Med, Res Way, Plymouth PL6 8BU, Devon, England
[3] Fudan Univ, Collaborat Innovat Ctr Brain Sci, Sch Life Sci, State Key Lab Med Neurobiol, Shanghai 200438, Peoples R China
来源：
JOURNAL OF MOLECULAR BIOLOGY | 2020年 / 432卷 / 08期
基金：
中国国家自然科学基金; 英国医学研究理事会;
关键词：
Autophagy; Selective autophagy; Huntington's disease; Huntingtin; Neu rodegeneration; INCLUSION-BODY FORMATION; SELECTIVE AUTOPHAGY; MOUSE MODEL; POLYGLUTAMINE EXPANSIONS; MOLECULAR-MECHANISMS; TRINUCLEOTIDE REPEAT; ACTIVATES AUTOPHAGY; RECEPTOR OPTINEURIN; MEDIATED AUTOPHAGY; NUCLEAR INCLUSIONS;
D O I：
10.1016/j.jmb.2019.11.012
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Huntington's disease (HD) is a monogenetic neurodegenerative disease, which serves as a model of neurodegeneration with protein aggregation. Autophagy has been suggested to possess a great value to tackle protein aggregation toxicity and neurodegenerative diseases. Current studies suggest that autophagyendolysosomal pathways are critical for HD pathology. Here we review recent advancement in the studies of autophagy and selective autophagy relating HD. Restoration of autophagy flux and enhancement of selective removal of mutant huntingtin/disease-causing protein would be effective approaches towards tackling HD as well as other similar neurodegenerative disorders. (C) 2019 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2673 / 2691
页数：19
相关论文
共 50 条
  • [31] Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease
    Luis-Ravelo, Diego
    Estevez-Silva, Hector
    Barroso-Chinea, Pedro
    Afonso-Oramas, Domingo
    Salas-Hernandez, Josmar
    Rodriguez-Nunez, Julia
    Acevedo-Arozena, Abraham
    Marcellino, Daniel
    Gonzalez-Hernandez, Tomas
    EXPERIMENTAL NEUROLOGY, 2018, 299 : 137 - 147
  • [32] Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington's disease mice
    Caron, Nicholas S.
    Byrne, Lauren M.
    Lemarie, Fanny L.
    Bone, Jeffrey N.
    Aly, Amirah E. -E.
    Ko, Seunghyun
    Anderson, Christine
    Casal, Lorenzo L.
    Hill, Austin M.
    Hawellek, David J.
    McColgan, Peter
    Wild, Edward J.
    Leavitt, Blair R.
    Hayden, Michael R.
    TRANSLATIONAL NEURODEGENERATION, 2024, 13 (01):
  • [33] Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models
    Yu, Meng
    Fu, Yuhua
    Liang, Yijian
    Song, Haikun
    Yao, Yao
    Wu, Peng
    Yao, Yuwei
    Pan, Yuyin
    Wen, Xue
    Ma, Lixiang
    Hexige, Saiyin
    Ding, Yu
    Luo, Shouqing
    Lu, Boxun
    CELL RESEARCH, 2017, 27 (12) : 1441 - 1465
  • [34] Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington's disease pathways
    Moily, Nagaraj S.
    Ormsby, Angelique R.
    Stojilovic, Aleksandar
    Ramdzan, Yasmin M.
    Diesch, Jeannine
    Hannan, Ross D.
    Zajac, Michelle S.
    Hannan, Anthony J.
    Oshlack, Alicia
    Hatters, Danny M.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2017, 83 : 103 - 112
  • [35] Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models
    Graham, RK
    Slow, EJ
    Deng, Y
    Bissada, N
    Lu, G
    Pearson, J
    Shehadeh, J
    Leavitt, BR
    Raymond, LA
    Hayden, MR
    NEUROBIOLOGY OF DISEASE, 2006, 21 (02) : 444 - 455
  • [36] Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformation
    Cariulo, Cristina
    Azzollini, Lucia
    Verani, Margherita
    Martufi, Paola
    Boggio, Roberto
    Chiki, Anass
    Deguire, Sean M.
    Cherubini, Marta
    Gines, Silvia
    Marsh, J. Lawrence
    Conforti, Paola
    Cattaneo, Elena
    Santimone, Iolanda
    Squitieri, Ferdinando
    Lashuel, Hilal A.
    Petricca, Lara
    Caricasole, Andrea
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (50) : E10809 - E10818
  • [37] Mutant Huntingtin Affects Diabetes and Alzheimer's Markers in Human and Cell Models of Huntington's Disease
    Chaves, Gepoliano
    Stanley, John
    Pourmand, Nader
    CELLS, 2019, 8 (09)
  • [38] Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease
    Miller, John P.
    Holcomb, Jennifer
    Al-Ramahi, Ismael
    de Haro, Maria
    Gafni, Juliette
    Zhang, Ningzhe
    Kim, Eugene
    Sanhueza, Mario
    Torcassi, Cameron
    Kwak, Seung
    Botas, Juan
    Hughes, Robert E.
    Ellerby, Lisa M.
    NEURON, 2010, 67 (02) : 199 - 212
  • [39] Transglutaminase 6 Is Colocalized and Interacts with Mutant Huntingtin in Huntington Disease Rodent Animal Models
    Schulze-Krebs, Anja
    Canneva, Fabio
    Stemick, Judith
    Plank, Anne-Christine
    Harrer, Julia
    Bates, Gillian P.
    Aeschlimann, Daniel
    Steffan, Joan S.
    von Hoersten, Stephan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [40] The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington's disease
    Nobrega, Clevio
    Conceicao, Andre
    Costa, Rafael G.
    Koppenol, Rebekah
    Sequeira, Raquel L.
    Nunes, Ricardo
    Carmo-Silva, Sara
    Marcelo, Adriana
    Matos, Carlos A.
    Betuing, Sandrine
    Caboche, Jocelyne
    Cartier, Nathalie
    Alves, Sandro
    BMC RESEARCH NOTES, 2020, 13 (01)
12345